Giving Compass’ Take:
• An article at Philanthropy News Digest reports on a partnership to make rapid COVID-19 testing affordable and accessible to low- and middle-income nations.
• How is rapid COVID-19 testing an essential ingredient in fending off the coronavirus? What are you doing to support sustainable, long-term solutions to provide rapid tests to countries with less access to such resources?
• Learn more about the full implications of rapid COVID-19 testing around the world.
The Access to COVID-19 Tools (ACT) Accelerator, a global collaboration focused on accelerating the production of and equitable access to COVID-19 tests, treatments, and vaccines, has announced an agreement to make affordable rapid COVID-19 antigen tests available in low- and middle-income countries (LMICs).
As part of the effort, the Bill & Melinda Gates Foundation has executed separate volume guarantee agreements with rapid diagnostic test producers Abbott and SD Biosensor to make a hundred and twenty million antigen rapid diagnostic tests available over six months to low- and middle-income countries at a maximum price of $5 per test. In addition, the Global Fund to Fight AIDS, Malaria…